OTC : SNPHY

Santen Pharmaceutical Co., Ltd. — Earnings Estimates

$12.22 USD

$0.57 (4.89%)

Volume
46
Average Volume
3.15K
Market Capitalization
$3.93B
P/E Ratio
16.46
Dividend Yield
2.02%
Price Target
Year High
$13.93
Year Low
$9.22
Day High
—
Day Low
—
Payout Ratio
$0.34
Current Ratio
$2.60

Annual earnings financials

SNPHY financial data with annual/quarterly toggle

SNPHY GAAP EPS - Annual & Quarterly

SNPHY Sales Revenue - Annual & Quarterly

SNPHY Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

SNPHY Estimated and Actual Revenue by Quarter
SNPHY Estimated and Actual EPS by Quarter
SNPHY Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-09-30 2 21.46B 21.64B 21.54B 18.12B 18.27B 18.19B
2026-06-30 2 20.03B 20.2B 20.11B 16.91B 17.05B 16.97B
2026-03-31 2 24.76B 24.97B 24.86B 20.9B 21.08B 20.98B
2025-12-31 3 22.21B 23.25B 22.9B 18.75B 19.63B 19.33B
2025-09-30 3 20.57B 21.32B 20.94B 17.37B 18B 17.68B
2025-06-30 4 20.68B 23.42B 21.64B 17.45B 19.77B 18.27B
SNPHY Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-09-30 2 12.99B 13.13B 13.06B 22.44B 22.63B 22.53B
2026-06-30 2 6.24B 6.3B 6.27B 20.95B 21.12B 21.03B
2026-03-31 2 - - - 25.89B 26.11B 25.99B
2025-12-31 3 - - - 23.22B 24.31B 23.95B
2025-09-30 3 - - - 21.51B 22.3B 21.9B
2025-06-30 4 - - - 21.62B 24.49B 22.63B
SNPHY Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-09-30 2 71.67B 72.27B 71.94B 1 39.88317 40.31557 40.082
2026-06-30 2 66.88B 67.44B 67.14B 1 19.14392 19.35147 19.23936
2026-03-31 2 82.69B 83.38B 83.01B 0 0 0 0
2025-12-31 3 74.16B 77.64B 76.47B 0 0 0 0
2025-09-30 3 68.69B 71.2B 69.92B 0 0 0 0
2025-06-30 4 69.04B 78.2B 72.26B 0 0 0 0